MIRA INFORM REPORT

 

 

Report Date :

22.05.2008

 

IDENTIFICATION DETAILS

 

Name :

HAU GIANG PHARMACEUTICAL JS COMPANY

 

 

Formerly Known As :

HAU GIANG PHARMACEUTICAL UNITED ENTERPRISES

 

 

Registered Office :

No. 288 Bis Nguyen Van Cu Str, Ninh Kieu Dist., Can Tho City, Can Tho province

 

 

Country :

Vietnam

 

 

Financials (as on) :

31.12.2007

 

 

Date of Incorporation :

1974

 

 

Com. Reg. No.:

5703000111

 

 

Legal Form :

Joint-Stock Company

 

 

Line of Business :

Manufacturing many kinds of dosage forms including hard capsules, tablets, coating tablets, soft capsules, etc.

Trading in various kinds of pharmaceutical products

Producing and trading in equipments to produce pharmaceutical products

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name
 
HAU GIANG PHARMACEUTICAL JS COMPANY
Vietnamese Name
 
CONG TY CO PHAN DUOC PHAM HAU GIANG
Former Name
 
HAU GIANG PHARMACEUTICAL UNITED ENTERPRISES

Former Vietnamese Name

 

XI NGHIEP LIEN HIEP DUOC HAU GIANG

Trade Name

 

DHG PHARMACEUTICAL JOINT – STOCK COMPANY

Current Abbreviate Name

 

DHG-PHARMA

Former Abbreviate Name

 

HG-PHARM

Listed on

 

Ho Chi Minh City Securities Trading Center

Current Type of Business

 

Joint-Stock Company

Founded

 

1974

Under management of

 

Ministry of Health

Re-established

 

1992

Establishment Decision

 

No.963/QD-UBT

Issued on

 

October 15th, 1992

Issued by

 

People’s Committee of Can Tho Province

Former business registration

 

No. 101001

Issued on

 

October 17th, 1992

Issued by

 

Planning and Investment Department of Can Tho City

Equitization Decision

 

2405/QD-CT.UB

Issued on

 

August 15th, 2004

Issued by

 

People’s Committee of Can Tho Province

New Business Registration

 

No. 5703000111

Issued on

 

September 15th, 2004

Issued by

 

Planning and Investment Department of Can Tho City

Current Registered Capital

 

VND 200 Billion

Former Registered Capital

 

VND 100 Billion

Tax Code

 

No. 1800156801

Total Employees

 

Around 2,000 persons

Qualification

 

Qualified

Note: The subject has just increased capital from 100 Billion VND to 200 Billion VND in January 4th, 2008.

 

 

 

 

 

 

 

ADDRESSES

 

Head Office:

Address

 

No. 288 Bis Nguyen Van Cu Str, Ninh Kieu Dist., Can Tho City, Can Tho province

Country

 

Vietnam

Tel

 

(84-710) 890 802/ 890 074

Fax

 

(84-710) 895 209

Email

 

dhgpharma@dhgpharma.com.vn

Former Email

 

hg-pharm@hcm.vnn.vn

Website

 

http://www.dhgpharma.com.vn

Former Website

 

http://www.hgpharm.com.vn

 

The subject has 18 branches, 20 distribution agents, and many pharmacy stores locating from the North to the South of Vietnam. Following are some of them:

Hochiminh city Branch

Address

 

No.97-0 Nguyen Duy Duong Str, F9, Dist.5, Hochiminh City, Vietnam

Tel

 

(84-8) 832 1095

Chief of Branch

 

Mrs. LAN NGOC VAN

 

Hanoi Branch

Address

 

No.89 Nguyen Van Troi Str, Phuong Liet Dist., Thanh Xuan Dist., Hanoi City, Vietnam

Former Address

 

No.31, Lang Ha Str, Dong Da Dist, Hanoi City, Vietnam

Tax code

 

No. 1800156801-031

Business Registration

 

No. 0113005568

Place issue

 

Planning and Investment Department of Hanoi City

Tel

 

(84-4) 212 3431

Fax

 

(84-4) 664 8272

Chief of branch

 

Mrs. NGUYEN THI BACH HONG

Identity card

 

No. 360114735

 

Hai Phong City Branch

Address

 

No. 4/345, Tran Nguyen Han Str, Le Chan Dist, Hai Phong City

Country

 

Vietnam

Tax code

 

No. 1800156801-007

Business Registration

 

No. 0213001057

Place issue

 

Planning and Investment Department of Hai Phong City

Tel

 

(84-31) 327 0046

Chief of branch

 

Mr. LE THANH HAI

Identity card

 

No. 100462151

 

Danang City Branch

Address

 

No. 225, Ong Ich Khiem Str, Da Nang City, Vietnam

Tax code

 

No. 1800156801-003

Business Registration

 

No. 3213000463

Place issue

 

Planning and Investment Department of Da Nang City

Tel

 

(84-511) 389 1408

Chief of branch

 

Mrs. DO THI HA

 

 

DIRECTORS

 

1. NAME

 

Mrs. PHAM THI VIET NGA

Position

 

General Director and Chairwoman

Hand Phone

 

++84 913 973 126

Qualification

 

Doctor

Date of birth

 

December 20th, 1951

ID Number

 

361139945

Resident

 

No.118/1 - 30/4 Str., Hung Loi ward, Ninh Kieu dist., Can Tho City

Nationality

 

Vietnamese

 

2. NAME

 

Mrs. LE MINH HONG

Position

 

Deputy General Director

Qualification

 

Pharmacist, Bachelor of Economics

Date of Birth

 

March 24th, 1959

Resident

 

288 Bis/17, Nguyen Van Cu Str, Ninh Kieu Dist., Can Tho City

Nationality

 

Vietnamese

Direct contact phone

 

(84-710) 890 790

 

3. NAME

 

Mr. LE CHANH DAO

Position

 

Deputy General Director

Qualification

 

Pharmacist, Master of Economics

Date of Birth

 

July 2nd, 1959

Resident

 

288/18 Bis Nguyen Van Cu Str, An Hoa Ward, Can Tho City

Nationality

 

Vietnamese

Office Tel

 

(84-710) 890 094

 

BUSINESS NATURE AND ACTIVITIES

 

The subject focuses on the following lines of business:

·         Manufacturing many kinds of dosage forms including hard capsules, tablets, coating tablets, soft capsules, etc. The subject has achieved certificates of GMP-ASEAN, GLP-ASEAN, GSP-ASEAN with quality assurance system complying with ISO 9001:2000.

·         Trading in various kinds of pharmaceutical products

·         Consultant service on medical and pharmaceutical. Bonded warehouse and rental service, maintaining and repairing goods, packages

·         Producing and trading in equipments to produce pharmaceutical products

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The subject imports many different kinds of pharmaceutical products from China, India, USA, Spain and Europe such as France, Germany, etc.

EXPORT: The subject exports pharmaceutical products to Moldova, Ukraina, Russia, Mongolia, Rumani, Cambodia, Laos and Korea..etc

 

 

BANKERS

 

1.       VIETCOMBANK (CAN THO BRANCH)

Address

 

No.7 Hoa Binh Avenue, Can Tho City, Can Tho Province

Country

 

Vietnam

Tel

 

(84-710) 820445

Fax No

 

(84-710) 820694

Telex                           

 

VCBCT VT

SWIFT             

 

BFTVVNVX 001

USD Account

 

0111370007798

 

2. INDUSTRIAL & COMMERCIAL BANK OF VIETNAM (CAN THO BRANCH)

Address

 

No. 9, Phan Dinh Phung Str., Can Tho City, Can Tho Province

Country

 

Vietnam

Tel

 

 (84-710) 820875

 

 

 

3. VIETNAM INTERNATIONAL COMMERCIAL JS BANK (CAN THO BRANCH)

Address

 

No.  19-21, Tran Van Kheo, Ninh Kieu Dist., Can Tho City, Can Tho Province

Country

 

Vietnam

Tel

 

 (84-710) 765995

Fax

 

 (84-710) 765939

 

 

SHAREHOLDERS

 

The subject was a State owned enterprise. It has just been equitized to be joint stock company in 2004. Following is its shareholders as of March 3rd 2007: (value of each share is 10,000 VND)

Following is the subject found shareholders:

I. State Owned Shares:

Shares

 

4,420,000 Shares

 
II. Private Shares:

1.NAME

 

Mrs. PHAM THI VIET NGA

Position

 

General Director and Chairman

Qualification

 

Pharmacist and Doctor of Economics

Date of birth

 

December 20th, 1951

ID Number

 

361139945

Issued on

 

June 01st, 1998

Issued by

 

Police Station of Can Tho City

Resident

 

No.118/1 - 30/4 Str., Hung Loi ward, Ninh Kieu dist., Can Tho City

Nationality

 

Vietnamese

Contact No.

 

++84 913 973 126

Values

 

29,000 Shares

 

2. NAME

 

Mrs. LE MINH HONG

Position

 

Deputy General Director

Qualification

 

Pharmacist, Bachelor of Economics

Date of Birth

 

March 24th, 1959

Resident

 

288 Bis/17, Nguyen Van Cu Str, Ninh Kieu Dist., Can Tho City

Nationality

 

Vietnamese

Direct contact phone

 

(84-710) 890 790

Values

 

15,934 Shares

 

 

3. NAME

 

Mr. LE CHANH DAO

Position

 

Deputy General Director

Qualification

 

Pharmacist, Master of Economics

Date of Birth

 

July 2nd, 1959

Resident

 

288/18 Bis Nguyen Van Cu Str, An Hoa Ward, Can Tho City

Nationality

 

Vietnamese

Office Tel

 

(84-710) 890 094

Values

 

11,872 Shares

 

4. NAME

 

Mr. PHAM HUU LAP

Position

 

Shareholder

Qualification

 

Master of Economics

Office Tel

 

(84-710) 890 032

Date of Birth

 

October 30th, 1973

Resident

 

178/46/11A, 3/2 Str, Can Tho City

Nationality

 

Vietnamese

Values

 

11,971 Shares

 

5. NAME

 

Mrs. NGUYEN THI HONG LOAN

Position

 

Chairman of Labor Union

Office Tel

 

(84-710) 893 507

Date of Birth

 

September 14th, 1958

Resident

 

369/11, Loi Nguyen B Str, Hung Loi ward, Can Tho City

Nationality

 

Vietnamese

Values

 

7,638 Shares

 

6. NAME

 

Mrs. DIEP BICH HUONG

Position

 

Shareholder

Date of Birth

 

September 18th, 1962

Resident

 

139 Nguyen Van Cu Str, Can Tho City

Office Tel

 

(84-710) 891 433

Nationality

 

Vietnamese

Values

 

6,826 Shares

 

7. NAME

 

Mrs. NGUYEN NGOC DIEP

Position

 

Shareholder

Resident

 

No. 5/8C – 30/4 Str, Xuan Khanh ward, Can Tho City

Nationality

 

Vietnamese

Values

 

6,495 Shares

 

8. NAME

 

Mrs. HA MY DUNG

Position

 

Shareholder

Date of Birth

 

October 5th, 1968

Office Tel

 

(84-710) 890 314

Resident

 

288/33 Nguyen Van Cu Str, Ninh Kieu Dist., Can Tho City

Nationality

 

Vietnamese

Values

 

7,096 Shares

 

9. NAME

 

ASIA VALUE INVESTMENT LTD

Address

 

Room 1703, Flr 17, Sunwah building, No.115 Nguyen Hue Str, Dist 1, Hochiminh city

Nationality

 

Vietnamese

Values

 

29,098 Shares

 
III. Staffs in the company.

Values

 

770,838 Shares

 

IV. Outside shareholders:

Values

 

4,683,232 Shares

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Good

Liquidity

 

Fairly prompt

Previous Payments

 

Above average

Current Payment status

 

Fairly prompt

Current Financial Situation

 

Fairly good

Legal Action

 

No recorded

Bankruptcy

 

No recorded

Public opinion

 

Good

Mode of payment

 

L/C, T/T

Sale methods

 

Directly export and though its agents network.

 

 

 

 

FINANCIAL DATA

 

           

           

BALANCE SHEET

Unit: VND 1,000,000

Balance Sheet Date

31/12/2007

31/12/2006

31/12/2005

31/12/2004

Number of week

52

52

52

52

ASSETS

A. Current assets & Short term Investment

674,440

333,095

228,197

161,664

I. Cash and cash equivalents

63,854

35,002

35,466

20,727

II. Short term investment

123,463

0

0

0

III. Receivables

250,370

167,105

79,040

49,777

 1. Receivables from customers

154,257

64,575

39,366

 2. Prepaid for providers

-

11,263

6,405

2,043

 3. Value-added tax deducted

-

466

0

0

 4. Internal receivables

-

0

0

7,960

 5. Other receivables

-

1,619

8,060

408

 6. Provision for bad receivables

-

-500

0

0

IV. Inventory

232,398

121,353

113,322

90,538

 1. Purchased goods in transit

 -

0

0

0

 2. Inventory raw materials

-

0

0

36,442

 3. Inventory appliance

-

0

0

0

 4. Cost for production and business in process

-

0

0

7,815

 5. Inventory finished products

-

0

0

38,416

 6. Inventory cargoes

232,398

121,853

113,322

7,865

 7. Entrusted goods for sale

 -

0

0

0

 8. Provision for devaluation of stocks

-

-500

0

0

V. Other current assets

4,355

9,635

369

622

 1. Advances

 -

0

0

395

 2. Prepaid expenses

-

6,280

369

197

 3. Pending expenses for transfer

-

0

0

0

 4. Pending assets

-

3,355

0

0

 5. Hypothecation, collateral and short run collateral

-

0

0

30

VI. Administrative

-

0

0

0

B. Fixed assets & Long term investment

268,421

149,752

64,060

54,995

I.  Fixed assets

216,567

143,167

55,348

52,020

1. Tangible fixed assets

111,295

81,120

46,332

41,480

   + Original cost

-

115,899

69,789

53,195

   + Accumulated depreciation value

-

-34,779

-23,457

-11,715

2.  Fixed assets of financing credit

0

0

0

0

3. Intangible fixed assets

105,272

62,047

9,016

10,540

   + Original cost

 -

62,047

9,016

10,540

   + Accumulated depreciation value

-

0

0

0

II. Long term investment

38,225

1,609

122

23

1. Long-term securities investment

 -

0

0

0

2. Joint-venture capital contribution

-

0

0

23

3. Other long-term investment

-

1,609

122

0

4. Provision for long-term investment devaluation

-

0

0

0

III. Capital construction in process

12,214

4,976

1,644

2,952

IV. Other

1,415

0

6,946

0

TOTAL ASSETS

942,861

482,847

292,257

216,659

LIABILITIES

A. Payables

292,412

312,406

161,290

120,810

I. Short term payables

291,598

291,128

138,523

100,505

1.Short-term borrowings

-

167,870

73,362

53,941

2. Due long-term liabilities

-

0

0

0

3. Payable to seller

-

18,478

16,286

14,831

4. Prepayment of buyer

-

169

163

373

5. Taxes and accounts dutiable

-

357

674

-1,560

6. Employee payments

-

32,548

13,494

7,075

7. Internal payments

-

0

0

0

8. Other payables

-

71,706

34,544

25,845

II. Long term payables

814

21,278

0

0

1. Long-term borrowing

 -

0

0

0

2. Long-term loans

-

0

0

0

III. Other liabilities

-

0

22,767

20,305

1. Disbursement payable

-

0

22,767

20,305

2. Pending assets

-

0

0

0

3. Receipts long-term collateral and deposit

-

0

0

0

B. Owner’s Equity

650,449

170,441

130,967

95,849

I. Capital and Funds

634,620

161,306

130,653

96,560

1. Working capital

200,000

80,000

80,000

80,000

2. Differences from assets revaluation

-

0

0

0

3. Exchange rate differences

-

0

0

29

4. Business development fund

55,768

52,598

12,197

0

5. Reserved fund

 -

11,795

400

0

6. Retained profit

378,852

16,913

38,056

16,531

7. Construction capital sources

 -

0

0

0

II. Other administrative and fund sources

15,829

9,135

314

-711

1. Provident funds for unemployment

 -

0

0

0

2. Welfare and reward funds

15,829

9,135

314

-711

3. Management funds of higher level

 -

0

0

0

4. Functional operation funds

-

0

0

0

5. Fund sources formed by fixed assets

 -

0

0

0

TOTAL LIABILITY AND EQUITY

942,861

482,847

292,257

216,659

 

 

PROFIT & LOSE ACCOUNTS

 

Description

FY 2007

FY 2006

FY 2005

FY 2004

Total revenue

1,285,210

873,072

556,190

452,196

Deductions Items

15,930

4,880

2,159

1,449

1. Net revenue

1,269,280

    868,192

554,031

450,747

2. Original rate of goods for sale

601,278

402,747

299,403

282,552

3. Combined Profit

668,002

    465,445

254,628

168,195

4. Sales costs

469,189

311,953

155,063

113,569

5. Enterprise administrative costs

60,319

55,881

39,787

19,259

6. Net income from business activity

138,494

97,611

59,778

35,367

Income from financial activities

5,789

514

406

281

Costs of financial activities

17,381

11,214

5,684

2,979

7. Net income from financial operation

-11,592

-10,700

-5,278

-2,698

Irregular income

1,351

1,406

1,187

243

Irregular expenditure

1,161

1,257

308

0

8. Irregular Profit

190

149

879

243

9. Total pre-tax profit

127,092

87,060

55,379

32,912

10. Income tax

0

17,412

11,077

9,215

11. After tax profit

127,092

69,648

44,302

23,697

 

 

 

 

 

 

FINANCIAL FACTORS

 

Description

FY 2007

FY 2006

FY 2005

FY 2004

Current Liquidity Ratio

2.31

1.14

1.65

1.61

Quick Liquidity Ratio

1.52

0.73

0.83

0.71

Inventory Circle

3.40

3.43

2.94

4.00

Average Receivable Period (days)

72.00

70.25

52.07

40.31

Utilizing Asset performance

1.35

1.80

1.90

2.08

Liabilities / Total Assets (%)

31.01

64.70

55.19

55.76

Liabilities / Owner’s Equity (%)

44.96

183.29

123.15

126.04

Income before tax/Total assets (%) ROA

13.48

18.03

18.95

15.19

Income before tax / Owner’s Equity (%) ROE

19.54

51.08

42.28

34.34

Income before tax/Total revenues (%) NPM

9.89

9.97

9.96

7.28

Gross profit /Total revenues (%) GPM

51.98

53.31

45.78

37.20

 

 

INTERPRETATION ON THE SCORES

 

DHG PHARMACEUTICAL JOINT – STOCK COMPANY (DHG-PHARMA) is one of the most traditional medicine manufacturers in the South of Vietnam. It is now expanding its activities and products nationwide. The subject has a wide distribution network including 18 branches, 20 distribution agents and many pharmacy stores locating from the North to the South of Vietnam.

Formerly, the subject was a State owned enterprise. It was set up in 1974 and has been under the direct management of the Ministry of Health since then. The subject was equitized in 2004 to be a joint-stock company with the registered capital of VND 80 Billion. The subject’s shares have just been listed on Ho Chi Minh City Securities Trading Center. Its stock code is DHG and market value is higher than nominal value about 26 times. The subject has issued more 20 Billion VND on June 20th 2007 and in Jan 8th, 2008, the Subject has increased to 200 billion VND.

 During its development, the subject has got many achievements. It was granted certificate of ISO 9001: 2000 from BVQI dated on march 10th, 1999. Besides, it also achieved certificates of GMP, GLP, GSP-ASEAN. Now, the subject is building a factory that meet standard of GMP-WHO.

The subject manufactures and trades in about 250 kinds of pharmaceutical products, some of them are famous ones such as: HAPOCOL, EYELIGHT, CEFUROXIM, KLAMENTIN, CHOLIVER, EUGICA, etc. And its product, which is more and more trustful for customers, is not only good in quality but also sold at reasonable price. At present, the subject’s production value is accounted for 10 percent of the whole country’s production value.

The subject’s products can compete with the foreign ones. At present, its products, CHOLIVER and EUGICA, are exported to many countries in the world such as: Cambodia, Laos, and Eastern European countries (Ukraine, Moldova, Russia, etc). The export turnover in 2005 was USD 481,000. In near future, the export turnover will be increased hard.

The subject is considered as the leading pharmaceutical company in Vietnam. Its premise & facility are good. The subject has re-organized its structure to be more active and more effective. Currently, it is one of the most effective enterprises of the Ministry of Health. Its turnover & profit are remarkable. Total value of product manufactured by the subject occupies 10% of total value of product manufactured by pharmaceutical companies in Vietnam. The total revenue increases year after year, especially after equitization. Its total revenue in 2005 was VND 554 billions, up 122 percent against 2004. The turnover of 2006 was 868,192 million VND, up 56.70% against 2005. Its total export volume attained 746,908 USD. Its products are mainly exported to Moldova, Ukraina, Laos, Campuchia, Mongolia, Korea. It plans to enter the markets of East Europe, EU and ASEAN countries.

 The subject is respected good by shareholders and investors. The dividend in 2005 and 2006 was 25%. Financial situation of the subject is fairly good. The liquidity of 2006 was a bit decreased compared to 2005. The average receive period was increased to 70 days. This thing made cash and cash equivalents of the end 2006 were not higher than that in 2005. In 2006, total assets were about higher two times than that in 2005. The assets were funded much by liabilities. The liabilities/total assets ratio was increased but it still safe for creditors and owners. The profitability was improved. One capital unit of owners made a half capital unit of profit.

The subject’s business result is good because of good management capacity. Mrs. PHAM THI VIET NGA is dynamic and creative person. She was assigned to the director of Hau Giang United Pharmaceutical Factory, precursor of the subject, in 1998. At that time, this company was in the bank of bankruptcy. Thanks to determination and suitable policy, she and the subject have current remarkable achievements. She has been awarded to be one of 100 excellent businessman of Vietnam in 2006. In last March 8, she was granted “Gold Rose – 2006” award.

Beside business operation, the subject also participates in many social operations. In 2005, the subject contributed VND 2 Billion for charity operation, financed USD 10,000 for 7 hospitals in Hochiminh city, Can Tho city, and Ca Mau province. Therefore, the image, prestige and position of the subject in Vietnam pharmaceutical industry are more and more elevated. The subject has clear development strategy. The management policy is always improved to meet the development and competition. The future prospect of the subject is bright.

In overall, after equitization, the organization structure and management ability of the subject are improved much. Its products have high competitiveness. The quality of its products is improved. The market share is higher. Its distribution network is allocated widely from the North to the South of Vietnam and is operating effectively. The management board always has good policy against sales teams.

The financial situation and operational base of the subject are healthy. The subject has capacity to meet financial commitments. No caution needed for normal business transactions.

The company has STRONG capacity to meet its financial commitments.

 

 

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions